not be displayed. A consultation with a vascular surgeon, with a view to possible carotid endarterectomy, was arranged, but this would have been a high-risk procedure for a person in such poor general health and the patient opted for conservative management. Within two months of presentation he underwent three sessions of panretinal photocoagulation to both eyes. The progression of ischaemia was stopped in the right eye, but the left developed iris neovascularization and rubeotic glaucoma, necessitating cryoablation of the anterior retina and cyclocryotherapy to the ciliary body to bring the intraocular pressure under control. Visual acuity is currently stable at 6/18 in the right eye and hand movements in the left eye.
COMMENT
Chronic hypoperfusion retinopathy is seen in severe stenosis or complete occlusion of an internal carotid artery. Patients often have a history of hypertension, peripheral vascular, cerebrovascular or ischaemic heart disease, or diabetes 1 . The condition is usually ipsilateral to the more severely affected carotid artery. The pathophysiology is that chronic low arterial perfusion pressure leads to retinal hypoxia. Slowing of the retinal circulation time causes dilatation and tortuosity of the retinal veins, breakdown of capillary walls, super®cial (¯ame-shaped) and deep (dot-blot) retinal haemorrhages, macular oedema and eventual neovascular proliferation in retina and iris which occurs as a response to the release of angiogenic factors from the ischaemic retina 2,3 . The fundoscopic picture resembles diabetic retinopathy but there are two distinguishing signs: in the early stages, hypoperfusion retinopathy affects the retinal midperiphery rather than the posterior pole; and it is usually unilateral 2, 3 . Contrasting features to a central retinal vein occlusion are the absence of optic disc swelling and the midperipheral location of the haemorrhages. In more profound ocular hypoperfusion, known as ocular ischaemic syndrome, the retinopathy is associated with anterior segment ischaemia as re¯ected in corneal oedema and ischaemic uveitis, neovascularization of the iris and raised intraocular pressure secondary to neovascular glaucoma. A poorly reactive pupil is often seen and patients complain of severe orbital pain 2 . Visual prognosis is poor 1 .
The differential diagnosis includes diabetic retinopathy, non-ischaemic central retinal vein occlusion, hyperviscosity syndromes such as polycythaemia, Waldenstro Èm's macroglobulinaemia, haemoglobinopathies, myelomatosis, and lymphoma 3 , all of which need to be excluded by investigations.
Chronic ocular ischaemia is treated by panretinal photocoagulation, which reduces the production of angiogenic factors by the hypoxic retina 2 . Reduction of intraocular pressure to improve ocular perfusion can be achieved by topical b-blockers and/or topical or systemic carbonic anhydrase inhibitors 1 . If possible, this is followed by management of the carotid occlusion by endarterectomy or a bypass from the super®cial temporal artery to the middle cerebral artery. Reports on the outcome of carotid endarterectomy in patients with ocular ischaemic syndrome show con¯icting results 1, 4, 5 . The decision about cerebrovascular surgery needs to be made on an individual basis, and the risk of perioperative complications, especially strokes, needs to be balanced against the expected bene®tÐ namely, stabilization of vision 2 .
symptoms were polyuria and nocturia. There was no vomiting or diarrhoea and he was not taking any medications. No other family member had a similar illness and there was no history of parental consanguinity.
On examination during an attack the quadriparesis was accid and associated with depressed tendon jerks. Muscles of the eyes, face, tongue, pharynx, larynx, diaphragm and sphincters were not involved. Blood pressure was normal. Serum potassium was persistently low even between the attacksÐ1.7 mmol/L (normal range 3.5±5.0). An excessive loss of potassium, chloride and magnesium was detected in the alkaline urineÐpotassium 300 mmol/24h (25±125), chloride 650 mmol/24h (110±250), magnesium 56 mmol/24h (2±5). He also had hypomagnesaemia, hypochloraemia and metabolic alkalosisÐmagnesium 0.5 mmol/L (0.8±1.2), chloride 89 mmol/L (98±106), bicarbonate 33 mmol/L (22±30), blood pH 7.48 (7.35± 7.45). The urinary calcium excretion was subnormal at 1.0 mmol/24h (2.5±7.5). Serum calcium was 2.5 mmol/L (2.2±2.6) and sodium 140 mmol/L (136±145). Thyroid function tests (T3, T4, TSH) were normal.
The hypomagnesaemia responded to oral magnesium supplements, but the hypokalaemia persisted despite large doses of oral and parenteral potassium. Oral indomethacin 25 mg 8-hourly was then started empirically and the patient became normokalaemic within 24 hours. He was discharged with advice to continue oral potassium and magnesium supplements along with indomethacin. He remains symptom-free and normokalaemic after four months of follow-up.
Episodic weakness beginning after age 25 is almost never due to primary periodic paralysis 1 . Further, a low serum potassium between attacks and absence of a similar family history should raise strong suspicion of a secondary disorder 2 . Thyrotoxicosis can mimic periodic paralysis, especially in Asians, and had to be ruled out here 3 . Secondary hypokalaemic periodic paralysis with normotension, alkaline urine and metabolic alkalosis is seen in hyperplasia of the juxtaglomerular apparatus with hyperaldosteronism 2,3 . Also known as Bartter's syndrome, this condition begins in childhood and presents with short stature, polyuria, polydipsia, and a tendency to dehydration during infancy or before school age. It is associated with polyhydramnios or premature delivery 4, 5 . Classic Bartter's syndrome is a severe congenital disease that is inevitably recognized before the age of 6 years 5 . Gitelman's syndrome is a milder variant, with more episodes of tetany and a later presentation. It also differs from Bartter's in being associated with hypocalciuria, so these two variants of primary renal tubular hypokalaemic metabolic alkalosis can easily be distinguished by measurement of urinary calcium 4, 5 . Renal magnesium wasting is seen in all patients with Gitelman's syndrome and in about one-third of those with Bartter's syndrome 5 . The tetany may be attributable to exacerbation of alkalosis and consequent low ionized plasma calcium in the presence of hypomagnesaemia. Usually the underlying condition is obvious, but recurrent episodes of transient weakness can sometimes be dif®cult to distinguish from primary hypokalaemic periodic paralysis 3 . The paroxysmal nature of the attacks is unexplained and it is not known whether the ionic shifts during the attacks are the same as in the primary hypokalaemic form. The timing of the attacks may relate to¯uctuations in catecholamine levels and associated regulation of sodium potassium ATPase function 2 . Insulin causes movement of potassium into cells which may account for the precipitation of paralysis by large carbohydrate meals.
The laboratory characteristics of classic Bartter's syndrome may be mimicked by treatment with loop diuretics, which bind to and inhibit the luminal sodiumpotassium-chloride cotransporter found in the thick ascending limb of loop of Henle. In the case of Gitelman's syndrome the laboratory characteristics resemble those induced by thiazides, which bind to and inhibit the luminal sodium-chloride cotransporter in the distal convoluted tubule 5 . The clinical features of Bartter's syndrome (and possibly also Gitelman's syndrome) are to a large extent caused by raised concentrations of prostaglandins 6 . By direct action and through stimulation of natriuresis, these compounds stimulate renin secretion, thereby promoting potassium wasting. They also have a direct effect on aldosterone biosynthesis. Indomethacin has been used in both syndromes, but especially Bartter's, for the bene®cial effects of inhibiting prostaglandin synthesis.
